- Migration of a sirolimus-eluting stent from the ostium of the left main coronary artery to the right deep femoral artery
-
Won KB, Kim BK, Ko YG, Hong MK, Jang Y, Shim WH
- KMID: 1793230
- Korean J Intern Med.
- 2013 Jan;28(1):116-119.
- doi: 10.3904/kjim.2013.28.1.116
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A 12-Month Single Arm Pilot Study to Evaluate the Efficacy and Safety of Sirolimus in Combination with Tacrolimus in Kidney Transplant Recipients at High Immunologic Risk
-
Lee J, Lee JJ, Kim BS, Lee JG, Huh KH, Park Y, Kim YS
- KMID: 2160593
- J Korean Med Sci.
- 2015 Jun;30(6):682-687.
- doi: 10.3346/jkms.2015.30.6.682
The optimal immunosuppressive strategy for renal transplant recipients at high immunologic risk remains a topic of investigation. This prospective single arm pilot study was undertaken to evaluate the safety and... -
- CITED
-
- Close
- SHARE
-
- Close
- Sirolimus Conversion Efficacy for Graft Function Improvement and Histopathology in Renal Recipients with Mild to Moderate Renal Insufficiency
-
Joo DJ, Yang CW, Jeong HJ, Lim BJ, Huh KH, Chung BH, Choi YJ, Kang SW, Kim YS
- KMID: 2129600
- J Korean Med Sci.
- 2014 Aug;29(8):1069-1076.
- doi: 10.3346/jkms.2014.29.8.1069
This study was designed to evaluate whether sirolimus (SRL) conversion effectively improves renal function and histopathology in calcineurin inhibitor (CNI)-treated renal recipients with mild to moderate renal insufficiency. SRL conversion... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
-
Kim BK, Ko YG, Oh S, Kim JS, Kang WC, Jeon DW, Yang JY, Choi D, Hong MK, Ahn T, Jang Y
- KMID: 1779626
- Yonsei Med J.
- 2010 Nov;51(6):823-831.
- doi: 10.3349/ymj.2010.51.6.823
PURPOSE: Previous studies suggested that asymmetric stent expansion did not affect suppression of neointimal hyperplasia (NIH) after sirolimus-eluting stents (SES) implantation. The aim of this study was to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
-
Cho YK, Hur SH, Kim HT, Kim IC, Park HS, Yoon HJ, Nam CW, Kim H, Han SW, Kim YN, Kim KB
- KMID: 1776660
- Korean J Intern Med.
- 2009 Dec;24(4):323-329.
- doi: 10.3904/kjim.2009.24.4.323
BACKGROUND/AIMS: Recent intravascular ultrasound (IVUS) studies of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have demonstrated a significant reduction in neointimal hyperplasia (NIH) based on simple coronary lesions. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
-
Tantawy A, Ahn CM, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK
- KMID: 2427116
- Yonsei Med J.
- 2017 Mar;58(2):290-295.
- doi: 10.3349/ymj.2017.58.2.290
PURPOSE: To compare the 1-year outcomes of a durable polymer Zotarolimus-eluting stent (ZES) versus a biodegradable polymer Biolimus-eluting stent (BES) in patients undergoing percutaneous coronary intervention. MATERIALS AND METHODS: A total... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
-
Kim U, Lee SH, Hong GR, Park JS, Shin DG, Kim YJ, Jang JS, Yang TH, Kim DK, Kim DS, Kim DK, Seol SH, Kim DI, Cho YK, Kim HS, Nam CW, Hur SH, Kim KB
- KMID: 1785986
- J Korean Med Sci.
- 2011 Oct;26(10):1299-1304.
- doi: 10.3346/jkms.2011.26.10.1299
Limited data are available on the long-term clinical efficacy of drug-eluting stent (DES) in diffuse long lesions. From May 2006 to May 2007, a total of 335 consecutive patients (374... -
- CITED
-
- Close
- SHARE
-
- Close
